Skip to content

Research on the specificity of the Deqi effect of the sparrow pecking moxibustion technique based on the heat-sensitive moxibustion robot technology

Research on the specificity of the Deqi effect of the sparrow pecking moxibustion technique based on the heat-sensitive moxibustion robot technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001260
Enrollment
Unknown
Registered
2025-06-26
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic nonspecific low back pain

Interventions

Experimental group:Heat-sensitive moxibustion robot Sparrow pecking moxibustion
Control group:The heat-sensitive moxibustion robot performs gentle moxibustion

Sponsors

Affiliated Hospital of Jiangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Those who meet the diagnostic criteria for chronic nonspecific low back pain in both Western and traditional Chinese medicine; 2) Right-handed aged between 18 and 70; 3) No other treatments related to low back pain have been received in the past month. 4) Visual Analogue Scale (VAS) =3 points Modified Japanese Orthopaedic Association Low Back Pain Score (M-JOA) > 10 points; 5) The subjects were conscious and could correctly express the moxibustion sensation. On the basis of a full understanding of this trial the subjects expressed their willingness to participate and signed the informed consent form at the same time.

Exclusion criteria

Exclusion criteria: 1) Those with low back pain lasting less than 12 weeks; 2) Those with clear pathological changes such as infection tumor tuberculosis deformity lumbar intervertebral disc protrusion nerve root syndrome or cauda equina syndrome fracture severe osteoporosis etc. Those with obvious symptoms of spinal cord compression or nerve root injury; 3) Patients with severe primary diseases such as cardiovascular and cerebrovascular diseases liver and kidney diseases lung diseases and hematopoietic system diseases and those with mental illness; 4) Pregnant and lactating women; There are serious underlying diseases: such as immune deficiency blood system diseases malignant tumors infectious diseases etc. 5) Those who experience fainting moxibustion or reject heat-sensitive moxibustion.

Design outcomes

Primary

MeasureTime frame
The difference in the deqi effect;Differences in clinical efficacy;The characteristic differences between cerebral cortex activation and brain functional connectivity;

Countries

china

Contacts

Public Contactzhudaocheng

Affiliated Hospital of Jiangxi University of Chinese Medicine

zdc8973@163.com13155818973

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026